Mical Pharms patent expiration
1. Ultravate patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8962028 | MICAL PHARMS | Topical steroid composition and method |
Jun, 2033
(8 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Nov 06, 2018 |
| New Patient Population(NPP) | Aug 31, 2023 |
Drugs and Companies using HALOBETASOL PROPIONATE ingredient
Market Authorisation Date: 06 November, 2015
Treatment: Use of a lotion containing halobetasol propionate for the treatment of corticosteroid-responsive dermatoses including psoriasis
Dosage: LOTION
How can I launch a generic of ULTRAVATE before it's drug patent expiration?
More Information on Dosage
ULTRAVATE family patents
